Ductal carcinoma in situ (DCIS) is a preinvasive malignancy that currently accounts for over
20% of newly diagnosed breast cancers in the US. This article reviews how clinical magnetic …

Detection of ductal carcinoma in situ (DCIS) has increased dramatically since the advent of
widespread screening for breast cancer in the early 1980s. DCIS is a preinvasive form of …

Before 2000, breast magnetic resonance imaging (MRI) was considered a relatively poor
imaging tool for ductal carcinoma in situ (DCIS), as a high percentage of false-negative …

Ductal carcinoma in situ (DCIS) is a preinvasive breast cancer that is often diagnosed as a
result of abnormal screening mammography. With the widespread implementation of …

Purpose Magnetic resonance imaging (MRI) is an important tool for characterizing invasive
breast cancer but has proven to be more challenging in the setting of ductal carcinoma in …

Ductal carcinoma in situ (DCIS) is a noninvasive malignancy that is commonly encountered
at routine breast imaging. It may be a primary tumor or may be seen in association with other …

PURPOSE: The objective of this study is to compare mammography with magnetic
resonance mammography (MRM) in the diagnosis of histopathologically verified subtypes of …

1504 Background: Mammographic screening is considered the mainstay for diagnosing pre-
invasive breast cancer (DCIS). However,(over) diagnosis of DCIS has become a major …

The incidence of ductal carcinoma in situ (DCIS) has increased over the past few decades
and now accounts for over 20% of newly diagnosed cases of breast cancer. Although the …

Rationale and Objectives To determine the upgrade rate of magnetic resonance imaging
(MRI)-detected ductal carcinoma in situ (DCIS) and to identify patient, imaging, and …